Back to company

Scanbio Denmark ApS: Financial statements 2024

CVR: 42107654

Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 16,399,410 and a net result of DKK 1,999,265 compared with DKK 4,013,557 the year before. That is an increase of 47.1% compared with the year before. Equity amounted to DKK 10,385,067. The solvency ratio was 35.1%. The company had 4 employees in the financial year.

Gross Profit
16,399,410 kr.
Profit/Loss
1,999,265 kr.
Equity
10,385,067 kr.
Total Assets
29,559,856 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-16.4 mio.2 mio.10.4 mio.4
2023-11.2 mio.4 mio.8.4 mio.4
2022-8.1 mio.3.9 mio.4.4 mio.4
2021-2.5 mio.448 t.488 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Scanbio Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Scanbio Denmark ApS: The 2023 annual report is outJul 10, 2024

Scanbio Denmark ApS has published its annual report for 2023. Gross profit came to DKK 11,150,985, and the net result was DKK 4,013,557.

About Scanbio Denmark ApS

Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity amounted to DKK 10,249,140.

Other financial years